KP Tissue Inc.
TSX:KPT.TOHousehold & Personal Products
Consumer Defensive
$12.34 -0.30%
-$0.04 today
- Market cap
- $123.80M
- Beta
- 0.42
- P/E (TTM)
- 33.9
- EPS (TTM)
- $0.39
- Dividend yield
- 5.46%
52W Low $8.73High $13.49
Volume 0.01M
Average 0.02M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$6.97M
FY 2024 · Annual
-0.1% YoYInvesting Cash Flow
$6.97M
FY 2024 · Annual
-0.1% YoYFinancing Cash Flow
-$6.97M
FY 2024 · Annual
Cash Flow Statement
CAD
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|---|---|
| Net Income | (1.95M) | 1.24M | (10.25M) | 1.96M | 2.43M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | (1.42M) | (2.21M) | (1.89M) | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 146K | 233K | (76K) | 287K | (595K) |
| Accounts Receivables | 874K | 2.07M | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 287K | 0 |
| Other Working Capital | (728K) | (1.84M) | (76K) | 0 | (595K) |
| Other Non-Cash Items | 786K | 1.89M | 18.83M | 4.73M | (1.84M) |
| Operating Cash Flow | (2.44M) | 1.15M | 6.62M | 6.98M | 6.97M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 5.6M | 5.56M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 5.56M | 6.62M | 6.98M | 6.97M |
| Investing Cash Flow | 5.6M | 5.56M | 6.62M | 6.98M | 6.97M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (5.6M) | (5.56M) | (6.62M) | (6.98M) | (6.97M) |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | (5.6M) | (5.56M) | (6.62M) | (6.98M) | (6.97M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (2.44M) | 1.15M | 6.62M | 6.98M | 0 |
| Free Cash Flow | (2.44M) | 1.15M | 6.62M | 6.98M | 6.97M |
Free Cash Flow
Net Income to FCF bridge
FY2024
= Net Income$2.4M
+ D&A$0
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$595.0K
- Other Non-Cash-$1.8M
= Operating Cash Flow$7.0M
- Capex$0
= Free Cash Flow$7.0M
Analysis
FY2024 free cash flow is $7.0M. FCF conversion is 286.6% of net income. Operating cash flow was $7.0M, with capex of $0. The largest bridge item is Other Non-Cash at -$1.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does KPT.TO generate free cash flow?
KP Tissue Inc. (KPT.TO) generated $6.97M of free cash flow in fiscal 2024.
How much operating cash flow does KPT.TO produce?
Operating cash flow was $6.97M, before capital expenditures of $0.00.
Continue the stock analysis
Jump to another research area for this company.